The Innovative Vector Control Consortium (IVCC) has embarked upon the next phase of its initial five year strategy with the launch of the first tranche of funded projects to develop new public health mosquito control products. The three projects, with partners Bayer CropScience and Syngenta, complement established IVCC projects developing improved mosquito control information systems.
The Syngenta project, in association with the London School of Hygiene and Tropical Medicine (LSHTM), will seek to develop a new long lasting Indoor Residual Spray (IRS) formulation to help control malaria and other diseases transmitted by mosquito vectors.
The first Bayer CropScience project, in partnership with the Medical Research Council, South Africa, the Liverpool School of Tropical Medicine (LSTM) and LSHTM, is also aimed at developing a long lasting IRS formulation for malaria and other vector borne diseases. The second Bayer project includes LSTM and the University of Liverpool as partners to modify current active insecticide ingredients to overcome pesticide resistance.
Commenting on the projects, IVCC Chief Executive Janet Hemingway said: The launch of these projects is the next stage in the development of IVCC as an organisation playing a key role in the development of new public health insecticides and better vector control information systems.
Several other IVCC-supported projects are already making good progress in the development of tools which will enable pesticides to be deployed more effectively and efficiently.
We are now looking at funding a further tranche of projects, including the development of entirely new active ingredients for pesticides that will greatly improve vector control in disease endemic countries.
Prof. Dr. Friedrich Berschauer, Chairman of the Board of Management of Bayer CropScience AG said: This partnership is a clear sign for us that our expertise and our long-term commitment
|Contact: Alan Hughes|
Liverpol School of Tropical Medicine